Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$28.23
-3.65%
Mkt Cap $2.49B
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
Implied Upside
+52.3%
Consensus $43.00 vs current $28.23
NASDAQ·Healthcare·Biotechnology
$28.23
-3.65%
Mkt Cap $2.49B
No recent rating data.
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
+52.3%
Consensus $43.00 vs current $28.23